These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5771356)

  • 41. [Controlled verification of the effectiveness of a new molecular combination of acetylcysteine and thiamphenicol in the otorhinolaryngological field].
    Balli R
    Otorinolaringol Ital; 1968; 37(1):76-84. PubMed ID: 5719453
    [No Abstract]   [Full Text] [Related]  

  • 42. [Contribution to rug therapy of deafness of the inner ear and tinnitus].
    Stoll HG
    Med Welt; 1967 Apr; 16():1034-7. PubMed ID: 5626261
    [No Abstract]   [Full Text] [Related]  

  • 43. [Introduction to the round-table discussion on the subject: "Rational use of drugs in otorhinolaryngological practice"].
    Lazeanu M
    Otorinolaringologie; 1972; 17(3):161-3. PubMed ID: 5030471
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-acting and short-acting diuretics in the treatment of hypertension.
    Pupita F; Belogi M; Ansuini R; Campolucci G
    Pharmatherapeutica; 1983; 3(7):475-81. PubMed ID: 6366805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Betamethasone phosphate in otorhinolaryngologic diseases].
    Bouche J; Bruker J
    Rev Laryngol Otol Rhinol (Bord); 1965; 86(9):794-800. PubMed ID: 5851577
    [No Abstract]   [Full Text] [Related]  

  • 46. [Intra-erythrocytic sodium and plasma renin activity in primary arterial hypertension before and after furosemide therapy].
    Urbański K
    Pol Tyg Lek; 1983 Jul; 38(27):843-7. PubMed ID: 6361711
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term control of hypertension with Diumide-K.
    Verguei A
    Br J Clin Pract; 1983 Feb; 37(2):67-8. PubMed ID: 6860541
    [No Abstract]   [Full Text] [Related]  

  • 48. [Antihypertensive therapy in chronic kidney failure. Comparison of pharmacologic effect of metolazone and furosemide].
    Groth H; Vetter H; Kuhlmann U; Burger R; Siegenthaler W; Vetter W
    Schweiz Rundsch Med Prax; 1983 Nov; 72(45):1423-7. PubMed ID: 6361725
    [No Abstract]   [Full Text] [Related]  

  • 49. Otorhinolaryngological evaluation of Phlogosam foam-spray.
    Zelen B
    Ther Hung; 1988; 36(3):136-9. PubMed ID: 3250002
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antihypertensive action of furosemide. A new diuretic derived from anthranilic acid].
    Carballo RS; Roque F; Pallavicini DR; Carlström JC; Larghi E
    Prensa Med Argent; 1965 Dec; 52(45):2868-71. PubMed ID: 5887538
    [No Abstract]   [Full Text] [Related]  

  • 51. [Minoxidil, timolol and furosemide, an effective hypotensive combination. Advantages and inconveniences].
    Ocón Pujadas J; del Río Pérez G
    Med Clin (Barc); 1983 Mar; 80(10):443-6. PubMed ID: 6855289
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical experiences with betahistine].
    Müller H; Buttkus R
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):151-3. PubMed ID: 6602925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O; Valenzuela MA; Salazar R
    Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical analysis of the use of tetracycline laurylsulphate in otorhinolaryngologic diseases].
    Pulido R
    Acta Otorinolaryngol Iber Am; 1968; 19(2):163-73. PubMed ID: 5721522
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prevalence of symptoms associated with blood pressure in normal and hypertensive population].
    Fasce E; Flores M; Fasce F
    Rev Med Chil; 2002 Feb; 130(2):160-6. PubMed ID: 11974528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on the role of dentition in the physiopathology of the hearing organ. I. Clinical and statistical studies on the effect of dentition on the hearing organ and hearing in 5000 patients treated in an otolaryngologic clinic].
    Semczuk B
    Ann Univ Mariae Curie Sklodowska Med; 1966; 21():167-74. PubMed ID: 5996249
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pain control in otorhinolaryngologic treatment using Dolo-Buscopan].
    Franz H
    Munch Med Wochenschr; 1966 May; 108(21):1166-8. PubMed ID: 6014173
    [No Abstract]   [Full Text] [Related]  

  • 58. [Apropos of the use of a balsamic essence in the treatment of certain diseases of the otorhinolaryngologic area].
    Foissin B; Yana M
    Clinique (Paris); 1965 Jun; 60(608):446-8. PubMed ID: 5845020
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hemorrhagic vasculitis, manifested in the otorhinolaryngological organs].
    Bareladze PL
    Zh Ushn Nos Gorl Bolezn; 1968; 28(2):94. PubMed ID: 5748135
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of antihypertensive therapy on the oxygen consumption of the myocardium. II. Furosemide and spironolactone].
    Sau F; Pisano MR; Seguro C; Pinna SG; Raffo M; Cherchi A
    Boll Soc Ital Cardiol; 1981; 26(12):1953-62. PubMed ID: 7185367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.